07.06.2022 18:30:00

SHAREHOLDER ALERT: Halper Sadeh LLP Investigates YMTX, GTYH, HR, POLY

NEW YORK, June 7, 2022 /PRNewswire/ -- Halper Sadeh LLP, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to:

logo (PRNewsfoto/Halper Sadeh LLP)

Yumanity Therapeutics, Inc. (NASDAQ: YMTX)'s sale of its product candidate, YTX-7739, and Yumanity's unpartnered discovery-stage neuroscience product candidates and targets to Janssen Pharmaceutica NV for $26 million in cash, and Yumanity's proposed merger with Kineta, Inc. If you are a Yumanity shareholder, click here to learn more about your rights and options.  

GTY Technology Holdings Inc. (NASDAQ: GTYH)'s sale to GI Partners for $6.30 in cash per share. If you are a GTY Technology shareholder, click here to learn more about your rights and options.

Healthcare Realty Trust Inc. (NYSE: HR)'s merger with Healthcare Trust of America, Inc. If you are a Healthcare Realty shareholder, click here to learn more about your rights and options.  

Plantronics, Inc. (NYSE: POLY)'s sale to HP Inc. for $40.00 per share. If you are a POLY shareholder, click here to learn more about your rights and options.  

Halper Sadeh LLP may seek increased consideration for shareholders, additional disclosures and information concerning the proposed transaction, or other relief and benefits on behalf of shareholders.

Shareholders are encouraged to contact the firm free of charge to discuss their legal rights and options. Please call Daniel Sadeh or Zachary Halper at (212) 763-0060 or email sadeh@halpersadeh.com or zhalper@halpersadeh.com.

Halper Sadeh LLP represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Contact Information:
Halper Sadeh LLP
Daniel Sadeh, Esq.
Zachary Halper, Esq.
(212) 763-0060
sadeh@halpersadeh.com
zhalper@halpersadeh.com 
https://www.halpersadeh.com

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/shareholder-alert-halper-sadeh-llp-investigates-ymtx-gtyh-hr-poly-301563060.html

SOURCE Halper Sadeh LLP

Nachrichten zu Proteostasis Therapeutics Inc Registered Shsmehr Nachrichten

Keine Nachrichten verfügbar.

Analysen zu Proteostasis Therapeutics Inc Registered Shsmehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!